1) Let's talk about the outsourcing business generally first. As Catalent has noted, only about one-third of today's global pharma finished dose form production is outsourced, even after many years of contract manufacturing advances. Why isn't more of the industry doing outsourcing? Is there an inherent limit to how much can be outsourced?